Arven Ilac Competitors and Similar CompaniesClear all
Arven Ilac's competitors and similar companies include Corhythm and Optina Diagnostics.
 Corhythm Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation. |  Optina Diagnostics Optina Diagnostics is developing an innovative tool that will transform AD research by enabling the identification of beta-amyloid (AB) plaques, a key biomarker of the disease.
| ||
Founding Date | Founding Date 2013 | Founding Date 2006 | Founding Date 2011 |
Type | Type Private | Type Private | Type Private |
Tags | |||
Locations | Locations TR HQ | Locations San Antonio, US HQ | Locations Montréal, CA HQ Montréal, CA |
Employees | Employees 1365% decrease | Employees 1 | Employees 27 |
Funding | |||
Latest funding round | Latest funding round N/A | Latest funding round $ 1.6m (over 8 years ago) | Latest funding round $ 3m (over 7 years ago) |
Total funding raised | Total funding raised N/A | Total funding raised $ 3.9m | Total funding raised $ 3m |
For sources of this data, please see the company profile
View Company Profiles
Corhythm
HQ
San Antonio, US
Employees
1
Corhythm is an early stage company developing a novel therapy for the treatment of atrial fibrillation.
View companyOptina Diagnostics
HQ
Montréal, CA
Employees
27
Optina Diagnostics is developing an innovative tool that will transform AD research by enabling the identification of beta-amyloid (AB) plaques, a key biomarker of the disease.
View company